课题基金 / 基金详情

UNS: Translation of nano-biorecognition into macroscopic counting for attomolar detection of biomolecules

UNS: Translation of nano-biorecognition into macroscopic counting for attomolar detection of biomolecules
UNS:将纳米生物识别转化为用于生物分子阿摩尔检测的宏观计数
批准号:
1512664
负责人:
Chuanbin Mao
金额:
$30.0万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-09-01 至 2019-08-31

项目摘要

项目成果

Chuanbin Mao的其他基金

相似基金

相关文献

中文摘要
翻译
1512664 MAO、传斌越来越多的证据表明,MicroRNAs是体液中的一种生物分子,可用作非侵入性生物标志物疾病。目前,用现有的方法对它们进行检测和定量,在浓度很低的情况下,重现性差,准确度低。这项研究将开发一种名为斑块计数(PC)的新方法,这种方法可能会产生更好的结果。体液中的microRNAs(MiRNAs)是一类非侵袭性阿尔茨海默病(AD)生物标志物。目前,它们的检测和定量是通过实时定量聚合酶链式反应(qRT-PCR)进行的,存在着重复性差等固有的局限性。在拟议的研究中,提出了一种空斑计数(PC)方法,该方法使用T7噬菌体在目标miRNA、T7噬菌体和噬菌体形成的病毒空斑之间建立一一对应关系。金NP(AuNP)探针与重组AuNP结合荧光T7噬菌体和能够与目标miRNA的一段杂交的寡核苷酸(ONT)双重功能化,以及磁性微粒(MMP)探针与另一能够与相同miRNA片段杂交的ONT功能化,共同捕获目标miRNA形成夹心复合体。然后,T7噬菌体通过与已报道的金结合多肽的竞争性结合而从复合体中释放出来,并被电镀以形成荧光斑块。荧光T7噬菌体的数量不仅等于目标miRNAs的数量,而且等于已形成的荧光斑块的数量。两个目标是:目标1:了解溶液和探针条件如何影响PC方法定量单个和多个AD相关miRNAs的准确性和灵敏度。该方法将用于AD生物标志物miRNAs(miR-9、miR-29a和miR-137)在水中的一系列稀释度的定量,以确定该方法的检测限。然后,PI将检查背景RNA、MMPs和AuNPs的大小以及盐的浓度如何影响三个目标miRNAs的单一和多重定量。目的2:验证PC策略在定量人血清中单个和多个miRNAs方面的应用。能够捕获目标miRNAs的MMPs将首先被用来从商业人体血清中磁性地去除先前存在的靶miRNAs,然后被用来制作具有已知目标miRNAs浓度的血清样本,然后进行目标1中描述的定量测试。智能优点:该项目将开发和优化一种新的简便的定量循环miRNAs的方法,具有高灵敏度、准确性和重复性。它克服了qRT-PCR技术的一些缺点,从而推动了miRNA诊断领域的发展。更广泛的影响:这项研究的结果可能会提高体液中microRNA的检测下限;因此,疾病诊断。更广泛的影响活动包括:(1)将加强关于生物纳米技术(BNT)的课程,以培养新一代科学家;(2)将激励社区大学和高中生在BNT学习实践技能,并选择接受高等教育;(3)将在俄克拉荷马州巩固美国原住民纳米技术推广(NANO)计划,以帮助美国原住民对科学事业感兴趣,并在就业市场上更具竞争力;(4)将在俄克拉何马州范围内提高公众对BNT的认识。
英文摘要
1512664 Mao, Chuanbin There is growing evidence that microRNAs, a type of a biomolecule in body fluids can be used as non-invasive biomarkers diseases. At present, detection and quantification of them is by current methods yields poor reproducibility and low accuracy when the concentration is very low. This research will develop a new novel approach called plaque counting (PC) method, which is likely to yield superior results. MicroRNAs (miRNAs) in body fluids are a class of non-invasive Alzheimer's disease (AD) biomarkers. At present their detection and quantification is by quantitative real-time polymerase chain reaction (qRT-PCR), which has inherent limitations such as poor reproducibility. In the proposed study, a plaque counting (PC) approach is proposed, which uses T7 phage to establish a one-to-one correspondence among target miRNA, T7 phages, and phage-developed viral plaques. A gold NP (AuNP)-probe dually functionalized with a recombinant AuNP-binding fluorescent T7 phage and an oligonucleotide (ONT) capable of hybridizing with one segment of the target miRNA and a magnetic microparticle (MMP)-probe functionalized with another ONT capable of hybridizing with a segment of the same miRNA co-capture the target miRNA to form a sandwich complex. T7 phages are then released from the complex by competitive binding of a reported gold-binding peptide and plated to develop fluorescent plaques. The number of fluorescent T7 phages is equal to not only that of the target miRNAs but also to that of the developed fluorescent plaques. Two aims are: Aim 1: Understand how the solution and probe conditions influence the accuracy and sensitivity of the PC method for quantifying single and multiple AD-associated miRNAs. The PC method will be used to quantify AD biomarker miRNAs (miR-9, miR-29a, and miR-137) with a series of dilutions in water to identify the detection limit of the method. The PI will then examine how the background RNAs, the sizes of MMPs and AuNPs, and the concentrations of saline influence both single and multiplexed quantifications of the three target miRNAs. Aim 2: Validate the use of the PC strategy for quantifying single and multiple miRNAs in human serum. MMPs capable of capturing target miRNAs will be first used to magnetically remove the pre-existing target miRNAs from the commercial human serum, which is then used to make serum samples with known concentrations of target miRNAs, followed by the quantification tests described in Aim 1. Intellectual Merit : This project will develop and optimize a new facile method for quantifying circulating miRNAs with high sensitivity, accuracy, and reproducibility. It overcomes some of the disadvantages of qRT-PCR technique and thus advances the fields of miRNA-based diagnosis. Broader Impacts : The results of this study is likely to improve detection limit of microRNA in body fluids; and therefore, disease diagnosis. Broader impact activities include: (1) A curriculum on bionanotechnology (BNT) will be strengthened to educate a new generation of scientists; (2) community college and high school students will be motivated to learn hands-on skills in BNT and choose to pursue higher education; (3) A Native American Nanotechnology Outreach (NANO) program will be solidified in Oklahoma to help Native Americans become interested in scientific careers and be more competitive on job markets; (4) Public awareness of BNT will be increased in Oklahoma statewide.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Collaborative Research: Chemical and Biological Quantum Nanosensors Based on Nanoparticle Molecules
CAREER: Genetically Modifiable Shape-Tunable Protein Nanotubes as Templates for Controlled Nano-Synthesis and Assembly
  • 批准号:
    0847758
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $50.0万
  • 财政年份:
    2009
  • 负责人:
    Chuanbin Mao
  • 依托单位:
Biomineralization and self-assembly of genetically modifiable nanofibers to build bone tissue engineering scaffolds
Gene delivery vectors inspired from the structure and assembly process of target-recognizing phage
海外基金